ITGB3 and cancer: The numbers of PS+ CD61+ CD45+ EVs were also counted (control median: 28/μL, range: 4–95/μL; cancer median: 35/μL, range: 2–729/μL) and were found to be higher in dogs with cancer, although without significance.